AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study

AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study

Abstract Background Most hepatocellular carcinoma (HCC) patients’ liver function indexes are abnormal. We aimed to investigate the relationship between (alkaline phosphatase + gamma-glutamyl transpeptidase)/lymphocyte ratio (AGLR) and the progression as well as the prognosis of HCC. Methods A total...

Full description

Bibliographic Details
Main Authors: Yan Liao, Rongyu Wei, Renzhi Yao, Liling Qin, Jun Li, Junxiong Yu, Weijia Liao
Format: Article
Language:English
Published: BMC 2021-02-01
Series:BMC Surgery
Subjects:
Hepatocellular carcinoma
AGLR
Prognosis
Biomarker
Online Access:https://doi.org/10.1186/s12893-020-01037-7

Internet

https://doi.org/10.1186/s12893-020-01037-7

Similar Items